Features of Cognitive Impairments in Patients with Comorbid Recurrent Affective and Panic Disorders

Objectives. To identify targets for medication and psychotherapy in the treatment of patients with comorbid recurrent affective and panic disorders based on results from studies of cognitive functions. Materials and methods. A set of pathopsychological methods (Schulte tables, correction test, 120-word test, cube drawing test, Binet and Berstein tests) was used. Cognitive status was studied in 60 patients with signs of recurrent affective (depressive) and panic disorders. ICD-10 diagnoses for the 27 patients making up the study group (SG) were recurrent affective disorder with mild and moderate depressive episodes (RAD, F33.0, F33.1) in combination with panic disorder (PD, F41.0). The control group (CG) included 33 patients with recurrent affective disorder (RAR, F33.0, F33.1) without panic disorder. Results and conclusions. All patients showed changes in the cognitive domain. Cognitive disorders in patients of the SG were more severe than those in patients of the CG. Cognitive functions in SG patients were characterized by being “left-hemisphere” impairments, in the form of paroxysmal emotional disorders with a predominance of fear and anxiety and dysfunction in the operation of a number of neuropsychological factors: successiveness, spatiality, inertia-mobility, for which the mediobasal and subcortical parts of the brain are responsible. Studies of cognitive impairments in remission provided evidence of some level of improvement in the cognitive domain in SG and CG patients, though there were no significant differences between the groups (p > 0.05). Targets for medication and psychotherapy in SG patients were attention, audioverbal memory, and components of thought (logical and spatial). The authors believe that use of neuropsychological correction of cognitive impairments is appropriate in patients of this group.

This is a preview of subscription content, access via your institution.


  1. 1.

    R. M. A. Hirschfeld, “The comorbidity of major depression and anxiety disorders: Recognition and management in primary care,” J. Clin. Psychiatry, 3, No. 6, 244–254 (2001), https://doi.org/10.4088/pcc.v03n0609.

    Article  Google Scholar 

  2. 2.

    N. Yu. Rakitskaya, “The evolution of diagnostic and therapeutic approaches to anxiety and depressive disorders,” Sib. Vestn. Psikhiatr. Narkol., 3, No. 54, 88–92 (2009).

    Google Scholar 

  3. 3.

    A. A. Gorbunova and E. V. Kolyutskaya, “Panic disorder and affective pathology (comorbidity aspects,” Zh. Nevrol. Psikhiatr., 114, No. 10, 9–13 (2014).

  4. 4.

    E. A. Korabel’nikova, “A modern approach to the diagnosis and therapy of panic disorder,” Poliklin. Revmatol. Nevrol., Spec. Iss., 2, 31–36 (2016).

  5. 5.

    I. A. Pogosova, “Clinical features of panic disorders combined with comorbid mental and narcological pathology,” Nevrol. Vestn. Zh. im. Bekhtereva, 3, 42–47 (2012).

    Google Scholar 

  6. 6.

    M. R. Restivo, M. C. McKinnon, B. N. Frey, et al., “Effect of obesity on cognition in adults with and without a mood disorder: study design and methods,” BMJ Open, 6, No. 2 (2016), https://doi.org/10.1136/bmjopen-2015-009347.

  7. 7.

    G. I. Papakostas and L. Culpepper, “Understanding and managing cognition in the depressed patient,” J. Clin. Psychiatry, 76, No. 4, 418–425 (2015), https://doi.org/10.4088/JCP.13086ah1c.

    Article  PubMed  Google Scholar 

  8. 8.

    A. A. Chepelyuk, M. G. Vinogradova, T. V. Kovalenok, et al., “Cognitive processes in patients with different structure of anxiety disorders,” Zh. Nevrol. Psikhiatr., 118, No. 3, 4–9 (2018).

    CAS  Article  Google Scholar 

  9. 9.

    S. A. Gordeev, S. I. Posokhov, G. V. Kovrov, and S. V. Katenko, “Psychophysiological features of panic and generalized anxiety disorders,” Zh. Nevrol. Psikhiatr., 113, No. 5, 11–14 (2013).

    CAS  Google Scholar 

  10. 10.

    M. G. Yanushko, M. V. Shamanina, and M. V. Ivanov, “Cognitive functioning parameters in patients with recurrent depressive disorder,” Sotsial. Klin. Psikhiatr., 27, No. 3, 27–31 (2017).

    Google Scholar 

  11. 11.

    D. M. Tsarenko, “Clinical and psychopathological features of cognitive impairment in anxiety-depressive spectrum disorders,” Mosk. Nauchn. Issled. Inst. Psikhiatrii, 5, 3–19 (2012).

    Google Scholar 

  12. 12.

    V. Ya. Semke and I. A. Pogosova, “Psychotherapy of comorbid phobic-anxiety and affective disorders,” Sib. Vestn. Psikhiatr. Narkol., 5, No. 62, 50–75 (2010).

  13. 13.

    B. D. Tsygankov and A. V. Yaltonskaya, . “Group cognitive-behavioral psychotherapy in the treatment of depressive disorders,” Zh. Nevrol. Psikhiatr., 112, No. 10, 68–74 (2012).

    CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to I. A. Pastukh.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 120, No. 7, Iss. 1, pp. 23–28, July, 2020.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tsygankov, B.D., Pastukh, I.A. Features of Cognitive Impairments in Patients with Comorbid Recurrent Affective and Panic Disorders. Neurosci Behav Physi 51, 283–288 (2021). https://doi.org/10.1007/s11055-021-01069-3

Download citation


  • recurrent affective disorder
  • panic disorder
  • comorbidity
  • neuropsychological and pathopsychological study methods
  • cognitive processes